Compared its EKOS Endovascular System to Inari Medical's FlowTriever for pulmonary embolism treatment using Truveta Data, finding a higher bleeding risk with the competitor device; the "REAL-PE" study was published and presented within 5 months, versus the years/millions an RCT would have required

Truveta is a real-world-data company owned by a consortium of major US health systems, supplying daily-updated de-identified EHR data and a genomic-linkage research program.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.